Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.855 -0.135 (-6.78%)
Streaming Delayed Price Updated: 3:27 PM EDT, Apr 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
35 36 Next >
News headline image
Ocugen Is Two Strikes in With a Third in the Books ↗
Ocugen failed to get energency use authorization for pediatric use of Covaxin. OCGN stock has tanked as a result. 
Via InvestorPlace
News headline image
68 Biggest Movers From Friday ↗
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday. Mexco Energy Corporation (NYSE: MXC... 
Via Benzinga
News headline image
Why Is Ocugen (OCGN) Stock Down Today? ↗
Shares of OCGN stock are in the red after the company's Covaxin Covid-19 vaccine was declined EUA by the FDA. Here's what you should know. 
Via InvestorPlace
News headline image
Why Ocugen Shares Are Falling ↗
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 22.8%... 
Via Benzinga
News headline image
Recap: Ocugen Q4 Earnings ↗
Ocugen (NASDAQ:OCGN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Also check... 
Via Benzinga
News headline image
Is Sweetgreen Stock a Buy After Earnings? 3 Analysts Weigh In on SG. ↗
Sweetgreen (SG) stock is rising as we check it with analysts following the fast-casual restaurants' most recent earnings report. 
Via InvestorPlace
News headline image
43 Stocks Moving In Friday's Mid-Day Session ↗
Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 45.2% to $29.33 after... 
Via Benzinga
News headline image
Is BABA Stock a Buy? 3 Analysts Weigh In on Alibaba. ↗
Alibaba (BABA) stock is in the news lately with the company's shares slipping and we're seeing what experts have to say. 
Via InvestorPlace
News headline image
Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection ↗
Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin. 
Via InvestorPlace
News headline image
Why Ocugen Shares Are Falling ↗
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 19.6%... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Open Lower; U.S. Economy Adds 678,000 Jobs ↗
U.S. stocks opened on a downbeat note this morning following the release of weekly jobless claims data. Following the market opening Friday, the Dow traded down 1.29% to 33,360.18... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo... 
Via Benzinga
News headline image
FDA Denies Pediatric EUA To Ocugen For Bharat Biotech's COVID-19 Vaccine Covaxin ↗
The FDA has declined to issue an Emergency Use Authorization (EUA) for Covaxin for active immunization to prevent COVID-19 in individuals 2 to 18 years of age. Ocugen... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck's Keytruda Evaluated In Combination With Microbiome Therapeutic In... 
Via Benzinga
News headline image
Looking Into Ocugen Inc's Recent Short Interest ↗
Ocugen Inc's (NASDAQ:OCGN) short percent of float has risen 8.35% since its last report. The company recently reported that it has 54.94 million shares sold short, which is 30.23... 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2022 ↗
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •... 
Via Benzinga
News headline image
63 Biggest Movers From Yesterday ↗
Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a... 
Via Benzinga
News headline image
Is OCGN Stock a Buy After 20% Plunge? One Analyst Thinks It Can Go to $15. ↗
Ocugen is down more than 20% after announcing a common stock offering. Could this possibly present a buying opportunity for OCGN stock? 
Via InvestorPlace
News headline image
7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio ↗
These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold. 
Via InvestorPlace
News headline image
40 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share... 
Via Benzinga
News headline image
Vertiv News: Why Is VRT Stock Plunging Today? ↗
Vertiv (VRT) stock isn't doing so hot on Wednesday following the release of the manufacturing company's earnings report for Q4 2021. 
Via InvestorPlace
News headline image
OCGN Stock Alert: The $50 Million Reason Ocugen Is Tanking Today ↗
After rising sharply in recent days, Ocugen shares are again falling on news that the company is issuing $50 million of common stock. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
News headline image
23 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the... 
Via Benzinga
News headline image
73 Biggest Movers From Yesterday ↗
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Revelation Biosciences (NASDAQ:REVB 
Via Benzinga
News headline image
Ocugen Is Too Uncertain as Time Runs Out for Covaxin’s Approval ↗
Ocugen's path to entry in the North American market is highly uncertain, making OCGN stock a remarkably risky bet at this point. 
Via InvestorPlace
News headline image
Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher ↗
U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led... 
Via Benzinga
News headline image
Production Updates Could Give Novavax Stock a Big Boost ↗
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits. 
Via InvestorPlace
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.